Massachusetts Society of Clinical Oncologists - Coherus BioSciences' Single-Dose (6mg/0.6mL), Prefilled Autoinjector Presentation of UDENYCA® (pegfilgrastim-cbqv) is Now Available in US

"The voice of oncology in Massachusetts."

Home
Resources
For Professionals
Drug Updates
Coherus BioSciences' Single-Dose (6mg/0.6mL), Prefilled Autoinjector Presentation of UDENYCA® (pegfilgrastim-cbqv) is Now Available in US

Coherus BioSciences' Single-Dose (6mg/0.6mL), Prefilled Autoinjector Presentation of UDENYCA® (pegfilgrastim-cbqv) is Now Available in US

May 22, 2023 2:12 PM | Katy Monaco (Administrator)

Coherus BioSciences, Inc., today announced that the single-dose (6mg/0.6mL), prefilled autoinjector presentation of UDENYCA® (pegfilgrastim-cbqv) is now available for commercial sale in the United States. Read More.

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329 | email: msco@mms.org